NUT carcinoma may defy typical staining patterns
-
By
-
Andrea Surnit
-
October 28, 2026
-
4 min
By
Andrea Surnit
October 28, 2026
In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.
September 24, 2026
Researchers assessed preferred hot drink temperature and consumption frequency across 2 large UK cohorts.
September 16, 2026
A rare intestinal lymphangioma caused life-threatening bleeding without typical laboratory features of protein-losing enteropathy
by Teraya Smith
October 5, 2026